These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2908595)

  • 21. Detection of minimal disease in patients with solid tumors.
    Pantel K
    J Hematother; 1996 Aug; 5(4):359-67. PubMed ID: 8877711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and immunologic diagnosis of cancer. Leukemia and lymphoma.
    Shiku H
    Tumour Biol; 1987; 8(2-3):156-60. PubMed ID: 3329399
    [No Abstract]   [Full Text] [Related]  

  • 23. [Minimal residual disease in leukemia].
    Morishima Y
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2063-9. PubMed ID: 1888177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical studies of autografting in acute lymphocytic leukaemia.
    Dicke KA; Spitzer G
    Clin Haematol; 1986 Feb; 15(1):85-103. PubMed ID: 2938864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J; Babusíková O; Kaiserová E; Jamárik M
    Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of hematologic malignancies by flow cytometry.
    Barlogie B; Latreille J; Freireich EJ; Fu CT; Mellard D; Meistrich M; Andreeff M
    Blood Cells; 1980; 6(4):719-44. PubMed ID: 7008871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advance in treatments of leukemia following the new concept of pathophysiology].
    Hirashima K
    Nihon Naika Gakkai Zasshi; 1988 Sep; 77(9):1367-72. PubMed ID: 3073173
    [No Abstract]   [Full Text] [Related]  

  • 28. Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?
    Bréard J; Mathé G; Consolini R
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):47-50. PubMed ID: 2525967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intercellular variation in the amounts of DNA, RNA and mass in a leukemia and a fibroblast cell population in vitro.
    Killander D
    Eur J Cancer (1965); 1967 Nov; 3(4):309-14. PubMed ID: 6078930
    [No Abstract]   [Full Text] [Related]  

  • 30. Allogeneic marrow transplantation in children with acute leukemia: careful comparison with chemotherapy alternatives required.
    Pulsipher MA; Hunger SP; Gamis AS; Wall DA; Grupp SA
    Leukemia; 2010 Jun; 24(6):1212-6. PubMed ID: 20428198
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemia.
    Meckenstock G; Heyll A; Schneider EM; Hildebrandt B; Runde V; Aul C; Bartram CR; Ludwig WD; Schneider W
    Leukemia; 1995 Feb; 9(2):260-4. PubMed ID: 7869761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
    Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia.
    Paredes-Aguilera R; Romero-Guzman L; Lopez-Santiago N; Burbano-Ceron L; Camacho-Del Monte O; Nieto-Martinez S
    Am J Hematol; 2001 Oct; 68(2):69-74. PubMed ID: 11559944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute leukemia with extramedullary presentation and mixed myeloid and lymphoid expression.
    Bayle C; Romdhane NB; Bastard C; Vannier JP; Hayat M; Lemerle J; Bernard A
    Pediatr Hematol Oncol; 1986; 3(3):293-6. PubMed ID: 3153242
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro treatment of leukemic bone marrow. What future for autologous bone marrow transplantation?].
    Gorin NC
    Presse Med; 1984 May; 13(21):1325-9. PubMed ID: 6233554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autograft of bone marrow for the treatment of acute leukemia: in vitro efficacy of anti-leukemic purification].
    Gorin NC; Salmon C; Duhamel G
    Ann Med Interne (Paris); 1986; 137(2):92-9. PubMed ID: 3521433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic approaches to the classification of non-Hodgkin's lymphomas.
    Grogan TM; Spier CM; Richter LC; Rangel CS
    Cancer Treat Res; 1988; 38():31-148. PubMed ID: 2908600
    [No Abstract]   [Full Text] [Related]  

  • 38. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia.
    Roberts WM; Estrov Z; Ouspenskaia MV; Johnston DA; McClain KL; Zipf TF
    N Engl J Med; 1997 Jan; 336(5):317-23. PubMed ID: 9011783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical review on features and cytogenetic patterns in adult acute myeloid leukemia with lymphoid markers.
    Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Bosly A; Doyen C; Carli MG; Piva N; Castoldi G
    Leuk Lymphoma; 1993 Mar; 9(4-5):285-91. PubMed ID: 8348065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody-ricin conjugate cytotoxic to cells expressing the common acute lymphoblastic leukemia antigen (CALLA).
    Pelham JM; Meyer BF; Herrmann RP; Davis RE; Raphael CL; Kraft N; Atkins RC
    Pathology; 1987 Apr; 19(2):124-30. PubMed ID: 2969499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.